In contrast, increased SOD1 and catalase activities were found in red blood cells from patients with T2D and PDT, suggesting that increased ROS production in PDT may enhance the antioxidant defense system, counterbalancing the pro-oxidant environment [33]. The gene discussed is CAT; the disease is type 2 diabetes mellitus.